J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well – CNBC
- J&J can produce up to 900 million coronavirus vaccine doses by April 2021 if trials go well CNBC
- Johnson & Johnson’s stock surges after earnings beat, raised dividend MarketWatch
- J&J beats profit estimates but coronavirus fuels forecast cut Yahoo Finance
- J&J raises dividend but cuts 2020 earnings outlook over coronavirus outbreak; shares rise CNBC
- JNJ Stock Rises After Medical Giant Tops First-Quarter Estimates Investor’s Business Daily
- View Full Coverage on Google News
Source: Air Tools